Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Diagnostic Technologies
Cue Health Q4 revenues decline 24% as firm expands, diversifies POC test menu
The company’s revenues have come predominantly from its COVID-19 testing product, but it is "executing well" on its strategy of expanding the test menu, CEO Ayub Khattak said.
March 16, 2023
Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease
The test provides early detection for infants with homocystinuria, an inherited disease that causes serious complications if left untreated.
March 16, 2023
Amplified Sciences developing dye-based tests for early detection of pancreatic cancer
Tests under development by the Purdue Research Foundation-affiliated startup use dyes to identify the potential for malignancy in fluid extracted from a cyst on the pancreas.
March 15, 2023
Molecular test in study identified hypnotizable patients for postoperative pain treatment
A molecular point-of-care test identified individuals for whom hypnosis may relieve postoperative pain, potentially reducing opioid use.
March 15, 2023
Bionano Laboratories launches new optical genome mapping tests
These tests offer genome-wide assessment of structural variants (SVs) and testing for most common and rare chromosomal abnormalities to assist clinicians in both diagnosing and managing their patients’ medical conditions.
March 15, 2023
Swedish study shows blood test may help in evaluating epilepsy
High levels of immune proteins before and after epileptic seizures may serve as epilepsy biomarkers that can be identified with a simple blood test.
March 14, 2023
Most Popular
Genetic causes identified for three rare diseases
Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease
FDA reissues EUA for Janssen COVID-19 vaccine, includes warning about risks of myocarditis, pericarditis
Duke University researchers discover biomarkers may identify early pancreatic cancer risk
Netherlands researchers combine CRISPR, bioluminescence in proof-of-concept infectious disease test
Werfen completes $2B acquisition of Immucor, expands presence in specialized diagnostics
Netherlands researchers combine CRISPR, bioluminescence in proof-of-concept infectious disease test
Glow-in-the-dark proteins, developed from the luciferase found in bioluminescent creatures, may make viral disease diagnosis quicker and easier, according to the researchers.
March 15, 2023
Noze nabs $1M grant from Bill & Melinda Gates Foundation to develop breath testing platform
The aim is to develop a platform that enables rapid screening and diagnostic testing for infectious diseases such as malaria and tuberculosis that impact millions of people, particularly in developing countries, Noze said.
March 14, 2023
Paige, Leica Biosystems expand partnership to enhance digital pathology workflows
Under the partnership, a co-branded version of Paige’s pathology platform will be introduced as the core interface between pathologists and Leica Biosystems hardware.
March 13, 2023
Sophia Genetics partnering with Agilent Technologies to offer cancer analysis solution
Through the partnership, the Sophia DDM Platform will be integrated with Agilent’s research-use-only SureSelect Cancer Comprehensive Genomic Profiling (CGP) Assay Kit.
March 14, 2023
Techcyte, Mayo Clinic to collaborate on algorithms for pathology platform
Techcyte’s Clinical Pathology AI Platform, which is CE-marked under IVDR and designated for research use only in the U.S., imports digital images of liquid-based samples from whole-slide scanners.
March 14, 2023
Long COVID less likely after Omicron than after original virus, Swiss researchers find
In a Swiss study, investigators have found that long COVID is less likely after Omicron infection than after infection by the original wild-type SARS-CoV-2 virus.
March 9, 2023
Page 1 of 274
Next Page
